From a purely monetary standpoint, genetic diversity has growing commercial uses [1]. Isolated ecosystems often contain genes and enzymes that let us access new areas of chemical space (this is big in drug discovery ATM). We recognize that sequencing methods at a given time may not capture all of the relevant info about a gene (ex. methylation, weird folds, expression), so having living samples as new technology becomes available is critical in this research.